HCPCS Level II · Temporary national codes (non-Medicare)
S0132Injection, ganirelix acetate, 250 mcg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About S0132
S0132 is an HCPCS Level II code in the S series (temporary national codes (non-Medicare)), describing injection, ganirelix acetate, 250 mcg.
It was added to HCPCS effective 04/01/2002.
Its Medicare coverage code is "I", meaning it is not payable by Medicare (another code or method is used).
Details
- Short description
- Inj ganirelix acetat 250 mcg
- Date added
- 04/01/2002
- Action effective
- 04/01/2002
- BETOS
- Z2
Related S01xx codes
- S0104Zidovudine, oral, 100 mg
- S0106Bupropion hcl sustained release tablet, 150 mg, per bottle of 60 tablets
- S0108Mercaptopurine, oral, 50 mg
- S0109Methadone, oral, 5 mg
- S0117Tretinoin, topical, 5 grams
- S0119Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)
- S0122Injection, menotropins, 75 iu
- S0126Injection, follitropin alfa, 75 iu
- S0128Injection, follitropin beta, 75 iu
- S0136Clozapine, 25 mg
- S0137Didanosine (ddi), 25 mg
- S0138Finasteride, 5 mg
Common questions about S0132
Is HCPCS S0132 still valid?
- Yes. S0132 is active in the CMS October 2026 HCPCS file.
Does Medicare cover S0132?
- Its coverage code is "I": it is not payable by Medicare (another code or method is used). Check the local coverage determination for your region.